Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Write for us
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • New for You
  • Covid-19
  • Video
  • Podcasts

Search Results for avifavir

Boom in Avifavir (Favipiravir) Demand to Treat COVID-19 Cases in Russia leads to Halt on All Exports

Russia’s Direct Investment Fund (RDIF), an active participant in funding the development of therapies and vaccines for that nation in […]

Boom in Avifavir (Favipiravir) Demand to Treat COVID-19 Cases in Russia leads to Halt on All Exports
4 weeks ago
Share
1

ChemRAR Group & RDIF Tout Robust Avifavir Demand Worldwide Targeting COVID-19

TrialSite has followed favipiravir with interest as this antiviral drug, originally from Japan, is approved and registered as a treatment […]

ChemRAR Group & RDIF Tout Robust Avifavir Demand Worldwide Targeting COVID-19
4 months ago
Share
0

Russia Ministry of Health Approves Avifavir (Favipiravir) for COVID-19 Patients—Cuts Duration of Illness by over 50%

Russia’s Ministry of Health issued a temporary registration certificate announcing that Avifavir became the world’s first Favipiravir-based drug to be approved […]

Russia Ministry of Health Approves Avifavir (Favipiravir) for COVID-19 Patients—Cuts Duration of Illness by over 50%
8 months ago
Share
6

Oxford’s PRINCIPLE Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19

The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they consider a pathbreaking “high-quality […]

Oxford’s Principal Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
2 days ago
Share
4

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19

Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19.  Approved […]

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19
5 days ago
Share
0

Favipiravir for COVID-19: Results Mixed and Research Ongoing

On January 6, The Lancet’s EBIoMedicine published a commentary on the use of Favipiravir for flu and COVID-19. They note […]

Favipiravir for COVID-19: Results Mixed and Research Ongoing
1 week ago
Share
0

Clinical Trials and Research Roundup | South Africa: SAHPRA Bans Ivermectin with Criminal Liability

South African Health Products Regulatory Authority (SAHPRA) Bans Ivermectin with Criminal Liability:The South African Health Products Regulatory Authority (SAHPRA) has […]

4 weeks ago
Share
4

Generic Drug Giant Quietly Submits Marketing Authorization Application for Reeqonus (Favipiravir) in Canada

Health Canada may be following India, Russia, some nations in Eastern Europe, and dozens of other nations who opt to […]

Generic Drug Giant Quietly Submits Marketing Authorization Application for Reeqonus (Favipiravir) in Canada
1 month ago
Share
1

Mumbai Hospital-led Phase 3 Clinical Trial Reveals the Efficacy of Favipiravir Targeting Mild to Moderate COVID-19 Patients in India

Glenmark Pharmaceuticals, a prominent Indian pharmaceutical firm, reports that the oral antiviral drug originating in Japan, Favipiravir, prevents the replication […]

Mumbai Hospital-led Phase 3 Clinical Trial Reveals the Efficacy of Favipiravir Targeting Mild to Moderate COVID-19 Patients in India
2 months ago
Share
2

NHS Greater Glasgow and Clyde & University of Glasgow Commence Favipiravir Clinical Trial Targeting Early Intervention of COVID-19

NHS Greater Glasgow and Clyde in collaboration with University of Glasgow now lead the first clinical trial in Scotland to investigate the […]

NHS Greater Glasgow and Clyde & University of Glasgow Commence Favipiravir Clinical Trial Targeting Early Intervention of COVID-19
2 months ago
Share
1

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
    In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.